ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SHPH Shuttle Pharmaceuticals Holdings Inc

0.418031
-0.00474 (-1.12%)
May 10 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 20,709
Bid Price 0.4052
Ask Price 0.434
News -
Day High 0.4394

Low
0.35

52 Week Range

High
2.75

Day Low 0.4028
Company Name Stock Ticker Symbol Market Type
Shuttle Pharmaceuticals Holdings Inc SHPH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.00474 -1.12% 0.418031 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.411 0.4028 0.4394 0.418031 0.422774
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
74 20,709 $ 0.4222238 $ 8,744 - 0.35 - 2.75
Last Trade Time Type Quantity Stock Price Currency
19:00:08 30 $ 0.4052 USD

Shuttle Pharmaceuticals Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
6.72M 16.00M - 0 -6.59M -0.41 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Shuttle Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SHPH Message Board. Create One! See More Posts on SHPH Message Board See More Message Board Posts

Historical SHPH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.430.440.390.414132820,993-0.01197-2.78%
1 Month0.4110.440.370.411527524,2330.007031.71%
3 Months0.37490.5450.35090.42380245,8320.0431311.50%
6 Months0.500.61830.350.4633692103,404-0.08197-16.39%
1 Year1.282.750.351.26457,885-0.86197-67.34%
3 Years24.05126.260.357.56833,394-23.63-98.26%
5 Years24.05126.260.357.56833,394-23.63-98.26%

Shuttle Pharmaceuticals Description

Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.

Your Recent History

Delayed Upgrade Clock